Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2022) on “Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age”. Following consultation with HIV experts, NACI has updated the suggested list of conditions for children 5 to 11 years of age to be considered moderately to severely immunocompromised.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.